Seagen Patent at Heart of $42M Verdict Endures Daiichi Challenge – Bloomberg Law

A Seagen Inc. patent whose infringement by Enhertu—a breast-cancer treatment marketed by Daiichi Sankyo Co. in the US via AstraZeneca PLC—led a …